MedPath

Imagery Rescripting and Cognitive Restructuring versus Treatment-As- Usual in the treatment of mild and severe depression: a randomized controlled trial

Not Applicable
Conditions
F33.2
F33.1
F32.2
F32.1
Recurrent depressive disorder, current episode severe without psychotic symptoms
Recurrent depressive disorder, current episode moderate
Severe depressive episode without psychotic symptoms
Moderate depressive episode
Registration Number
DRKS00030809
Lead Sponsor
Zentrum für Integrative Psychiatrie Kiel
Brief Summary

There was a statistically significant interaction between time and group, (Greenhouse–Geisser F(1.00, 31) = 16.29, p < .001, partielles ?² = .34.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

main diagnosis: moderate or severe depressive episode (F32.1 or F32.2) or a
recurrent depressive disorder, current episode moderate or severe (F33.1 or 33.2)
HAMD > 21 and BDI-II >19

Exclusion Criteria

Treatment by electroconvulsive therapy or intake of benzodiazepines. Serious diseases, which make a participation disproportionate (e.g. advanced tumor disease) or distort the study results (e.g. mental disability or chronic inflammatory disease) .
Patients with acute suicidality (missing capacity to consult, cognitive constraint on suicidal plans or no reason to survive)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In the fourth psychotherapeutic session severeness of depression will be assessed by widely known measure: Hamilton Depression Rating Scale (HDRS) to show effectiveness of preceding intervention
Secondary Outcome Measures
NameTimeMethod
In the fourth psychotherapeutic session severeness of depression will be assessed by widely known self report measure: Beck-Depression-Inventory-II ; BDI-II) to show effectiveness of preceding intervention.<br>Additionally assessment of daily step count will be executed to gain a correlate of severeness of depression
© Copyright 2025. All Rights Reserved by MedPath